By Products and Services
- Biobanking Equipment
- Temperature Control Systems
- Freezers and Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators and Centrifuges
- Alarms and Monitoring Systems
- Accessories and Other Equipment
- Biobanking Consumables
- Laboratory Information Management Systems
- Biobanking and Repository
- Lab Processing
- Qualification/Validation
- Cold Chain Logistics
- Other Services
By Biospecimen Type
- Human Tissues
- Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimen
By Biobank Type
- Physical/Real
- Tissue
- Population Based
- Genetic
- Disease Based
- Virtual
By Application
- Therapeutics
- Drug Discovery and Clinical Research
- Clinical Diagnostics
- Others
By Region
The market is fragmented into by products and services, by biospecimen type, by biobank type, by application and region. The products and services segment is categorized into biobanking equipment, biobanking consumables, laboratory information management systems, biobanking and repository, lab processing, qualification/validation, cold chain logistics and other services. Equipment like freezers, barcode readers, cell separators, alarm monitoring systems and thawing equipment are available for the process of biobanking like sample analysis, collection, transport and storage. Laboratory information management systems are utilized in different biobank workflows like sample collection, patient consent, sample storage, accession and distribution. But these workflows can only be used for newer samples and in case of older samples, the usage of these workflows is reduced to data storage. National Cancer Institute developed a Biobank Economic Modeling Tool in 2017 was used for undertaking a survey which concluded that the consumables held the largest biobanking market share owing to its integrated usage with equipment that are based on novel technologies like automated sample processing shall boost the market growth. Rise in the clinical trial outsourcing has bolstered the proliferation of the market. The application segment is categorized into therapeutics, drug discovery and clinical research, clinical diagnostics and others. The therapeutics segment is anticipated to lead the market owing to rapid advancements in biologic production has boosted the augmentation of the market. The biospecimen type segment is bifurcated into human tissues, organs, stem cells and other biospecimens. Serum or plasma, solid tissues, peripheral blood, bone marrow and whole blood are some specimens that are generally stored in the biorepositories. The human tissue segment is predicted to dominate the market owing to advancements in cell acquisition technology and a wide range of stem cell applications for regenerative medicines shall boost the growth of the market.
The North America region is expected to lead the market, and this is primarily due to various strategic partnerships and collaborations between ley market players for developing advanced technologies for biobanks in the region. The European region is predicted to grow at a substantial rate during the forecast period owing to advancements in infrastructure for storage, retrieval and processing biospecimens. The BBMRI and EuroBioBank are two of the largest biobanking networks currently operating in the region for bolstering research and medical activities.